Chapter 50: Antidiabetic Drugs & Glycemic Control

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

We are back with a fresh stack of research, a lot of coffee, and a very specific mission today.

We are tackling a topic that I think a lot of people assume they understand until they actually have to manage it clinically.

Oh, it is exactly one of those topics.

It really is.

You think you know it because you hear the word diabetes every single day.

I mean, it's in the news, it's in your family, it's just everywhere.

But when you actually crack open the pharmacology text,

specifically chapter 50 of the pharmacology,

a patient -centered nursing process approach, 12th edition, you realize that knowing diabetes and managing diabetes safely are two completely different universes.

That is the perfect way to frame it.

And that really is our focus today.

We're taking a microscope to chapter 50.

Antidiabetics.

We aren't just skimming the surface of, you know, sugar is high, give insulin.

We are going to decode the entire mechanism.

We're going to move strictly through this chapter and understand the pathophysiology, what is physically breaking down in the body, the absolute minefield that is insulin therapy, and this exploding world of oral and injectable agents that seems to get more complicated every single year.

And we are going to keep this, as we agreed,

nursing student friendly.

We want this to be accessible.

We want it to be clear.

But above all, we want to focus on safety and clinical judgment, because with antidiabetics, the margin for error can be, well, it can be razor thin.

That's a good way to put it.

If you mess up an antibiotic dose, usually the patient just gets a stomach ache.

You mess up an insulin dose, you can kill a patient in minutes.

That is the reality check we need right at the top.

So let's at the scene.

We have to start with the hardware.

We're talking about the pancreas.

It's sort of sitting there tucked just to the left and behind the stomach, doing a lot of heavy lifting.

It's a workhorse.

It truly is.

And to really understand the drugs, you have to understand that the pancreas is actually two glands in one.

It has a dual identity.

Two glands.

You have the exocrine function, which is busy secreting digestive enzymes into the duodenum to help break down your lunch.

But for this deep dive, we are completely ignoring that side of the house.

We're laser focused on the endocrine section.

The islets of Langerhans.

Sounds like a vacation spot, doesn't it?

Booking a trip to the islets.

It really does.

But it's actually the control center for your body's energy.

Right.

These are cell clusters nestled within the pancreas.

And inside those clusters, you have two key players, the alpha cells and the beta cells.

And the best way to think about them is as the gas and the break for your blood sugar.

OK, let's unpack that analogy because I think it helps visualize what's happening.

Who's the gas?

The alpha cells.

They secrete a substance called glucagon.

Now, imagine you haven't eaten for a while.

Skip breakfast.

Maybe you skipped breakfast.

Your blood sugar drops.

The alpha cells sense that drop and release glucagon.

Glucagon goes straight to the liver and tells it, hey, unlock the storage.

It breaks down glycogen, which is stored sugar, into active glucose.

So glucagon raises blood sugar.

It's a hyperglycemic substance.

Which makes the beta cells the break.

Exactly.

The beta cells secrete insulin.

Insulin is the regulator.

It regulates glucose metabolism.

Without insulin, glucose is just floating around in your blood, totally useless.

It cannot get inside the cell to be used for energy.

It's locked out.

It's locked out.

Insulin unlocks the cell door, lets the sugar in, and consequently lowers the blood sugar level.

So insulin is the anti -diabetic agent.

And the text mentions that the beta cells make up the majority of the pancreas, right, something like 75%.

About 75%.

Whereas the alpha cells are about 20%.

And in a healthy person, this balance is perfect.

It's a constant seesaw, you know, micro -adjusting all day long to keep us in homeostasis.

When that balance is disrupted,

specifically when there is insufficient insulin secretion from those beta cells, that is when we enter the territory of diabetes mellitus.

And we need to make a quick distinction here because the text flags it, and I know students get tripped up on this all the time.

Diabetes mellitus versus diabetes insipidus.

They sound the same.

Are they cousins?

Not even related.

Not at all.

They share a first name, diabetes, which basically just comes from the Greek word for siphon or passing through.

Oh, interesting.

I'm not referring to the excessive urination.

But diabetes mellitus, which we're discussing, is a disorder of the pancreas dealing with glucose metabolism, sugar.

Diabetes insipidus is a disorder of the posterior pituitary gland.

It's an issue with antidiuretic hormone, ADH.

Totally different system, totally different mechanism.

So on a test, if you see diabetes insipidus.

Do not reach for the insulin.

Got it.

So focusing on mellitus,

the core problem is insufficient insulin, and the result is hyperglycemia.

High blood glucose.

And the text lists the classic symptoms, the three P's.

I feel like every nursing student has these tattooed on their brain, but let's run through them because the Y behind them is fascinating.

The three P's.

First, polyuria.

Increased urine output.

Why does that happen?

Is it just because they're drinking a lot of water?

No, it's physics.

It's osmosis.

When your blood sugar is sky high, the kidneys cannot filter it all back into the blood.

Some of that sugar spills into the urine.

Now sugar is a solute.

Solutes pull water.

So as the sugar leaves the body through the urine, it drags a massive amount of water with it.

An osmotic diuretic effect.

That's the term, exactly.

Which leads directly to the second P.

Colidipsia.

Increased thirst.

Because you are losing so much fluid through polyuria, you become dehydrated at a cellular level.

Your brain screams thirst to try to replace that water.

And the third one, which always seems a bit counterintuitive to people.

Polyphagia.

Increased hunger.

Because you have tons of sugar in your blood, why are you hungry?

This is the concept of starving in the midst of plenty.

Even though there is plenty of sugar circulating in the vessels, without insulin, the cells can't use it.

The cells are literally starving.

So the body signals hunger to try to get more energy.

You eat, blood sugar goes even higher, but the cells still starve.

It is a vicious cycle.

That makes so much sense.

Now not all diabetes is the same.

The text breaks this down in table 50 .1.

We have four main types we need to understand.

Let's start with type 1.

Type 1, it accounts for about 10 to 12 % of cases.

The text points to viral infections, environmental conditions, and genetic factors as contributors.

But the mechanism is key.

It is beta cell destruction.

So the factory is shut down.

Essentially, yes.

The factory has been demolished.

There is no insulin being produced.

This is crucial for pharmacology because it means oral drugs that work by stimulating the pancreas.

Or work.

They won't work here.

You cannot stimulate a factory that has been demolished.

These patients must have insulin injections.

Contrast that with type 2.

Type 2 is the most common.

About 85 to 90 % of cases.

Here, heredity and obesity are major factors.

The beta cells are still functioning to some degree,

but there is insulin resistance.

The body isn't using the insulin effectively, or there just isn't quite enough to meet the demand.

And interestingly, the text mentions that about one -third of patients with type 2 diabetes end up needing insulin eventually.

Correct.

Patients who start on oral drugs may become insulin -dependent years later as the disease progresses and the beta cells just, you know, well, they wear out from overwork.

Then we have this category called secondary diabetes.

This one always surprises people.

This is diabetes caused by other medications.

It is.

We call it secondary diabetes because it's secondary to another cause.

Clucocorticoids are the big offender here.

Seroids.

Drugs like prednisone or cortisone.

You see this in the hospital all the time.

A patient comes in for an asthma flare -up, gets put on high -dose steroids, and suddenly their blood sugar is 250.

And the nurse thinks, I didn't know they were diabetic.

They might not be.

But steroids tell the liver to dump glucose.

It causes temporary hyperglycemia.

Usually when you stop the drug, the blood sugar returns to normal.

But the thiazide diuretics like hydrochlorothiazide and epinephrine can also do it.

It's a critical thing to watch for.

And the fourth type is gestational diabetes.

Occurring during the second or third trimester of pregnancy.

The text explains that hormones like progesterone, cortisol, and human placental lactogen increase during pregnancy.

These hormones can inhibit insulin usage.

So the body is fighting against its own insulin.

Yes.

Glucose gets mobilized from tissues to help the baby grow.

Blood sugar goes up.

After pregnancy, it often resolves.

But, and this is important, some patients may develop type 2 diabetes later in life because of this sort of stress test on the pancreas.

Okay, so we know the types.

How do we diagnose it?

The text gives us some very specific numbers for hemoglobin A1C.

HbA1C is the gold standard because it reflects the average glucose level over the last three months.

Why three months?

Because that's the lifespan of a red blood cell.

Glucose attaches to the hemoglobin.

It becomes glycosylated.

So it gives us a long -term picture.

You can't cheat the A1C by fasting for one day before your appointment.

So what are the numbers we need to know?

For a diagnosis of diabetes, the HbA1C is 6 .5 % or greater.

Pre -diabetes is 5 .7 % to 6 .4%.

And if you are monitoring treatment, the goal for a diabetic patient is to keep that HbA1C below 7%.

Below 7 % is the target.

And just for context, normal fasting blood glucose is 70 to 99mgdL.

Correct.

And if it goes above 180mgdL, that is when you start seeing glycosuria.

Sugar in the urine.

The glucose in the urine.

That's the threshold where the kidneys just can't hold it back anymore.

Okay, we have the background.

Now we are going to dive into the drugs.

And we have to start with the big one.

Insulin.

The cornerstone of treatment for type 1 and, of course, a major player for type 2.

The history here is fascinating.

The text mentions we used to use pancreas tissue from pigs and cows.

We did.

Pork and beef insulin.

But today, we use recombinant DNA technology, or rDNA.

We manufacture human insulin and human insulin analogs.

Which is better because...

Less risk of allergy and less insulin resistance.

It's structurally identical or, in some cases, modified specifically to improve performance.

We aren't relying on animal sources anymore.

Now before we get into the types of insulin, we have to talk about concentration.

This is a massive safety issue.

Massive.

The standard concentration is U100.

That means there are 100 units of insulin per milliliter.

But there's another one.

U500.

500 units per milliliter.

This is highly concentrated.

It is five times as potent.

It's only available as regular insulin.

And it is reserved for emergencies or patients with severe insulin resistance who need more than 200 units a day.

And the text gives a very specific warning about syringes here.

You must use U100 syringes for U100 insulin.

The syringe must match the insulin.

Typically, U100 syringes have orange caps.

If you use the wrong syringe, say a standard syringe with U500 insulin, the overdose potential is catastrophic.

You'd think you were giving 10 units, but you're actually giving 50.

Safety first.

And speaking of safety, there's a note about preparing the vial.

Roll.

Do not shake.

Roll.

Do not shake.

Especially for cloudy insulin.

Shaking creates bubbles.

Bubbles take up space in the syringe, and that leads to an inaccurate dose.

Rolling between the palms mixes the ingredients gently without frothing it up.

Okay, let's get into the types of insulin.

The text presents table 15 .2, which breaks them down into four categories.

Rapid, short, intermediate, and long acting.

Expert.

Walk us through these.

Let's start with rapid acting.

Okay.

Rapid acting.

These are clear solutions.

Examples are insulin Lispro, insulin Aspart, and insulin Glulucine.

What makes them rapid?

They are human analogs.

The amino acids have been swapped around to prevent the molecules from clumping together.

This allows them to enter the blood circulation very, very quickly.

How quickly?

Onset is 10 to 15 minutes.

Peak is 30 to 90 minutes.

So if the onset is 10 minutes, when do I give it?

You administer it 10 to 15 minutes before a meal.

But here is a crucial rule.

Food must be present.

You do not give this if the breakfast tray is still down the hall.

If you give rapid acting insulin and the food doesn't arrive, the patient will bottom out.

This is the food on the tray rule.

Got it.

Next up,

short acting.

This is your regular insulin.

Examples like Humulin R or Novelin R.

It is also clear.

And there is a very special distinction for regular insulin.

Yes.

Regular insulin is the only type that can be administered intravenously, IV.

Oh, that's important.

All the others are sub -Q only.

If you have a patient in DKA diabetic ketoacidosis and they need an insulin drip, it will always be regular insulin.

What's the timing on this one?

Onset is about 30 minutes subcutaneously.

Peak is 1 .5 to 3 .5 hours, so you give it about 30 minutes before meals.

Okay.

Moving to intermediate acting, this is where things get cloudy.

Literally cloudy.

The classic example is NPH,

neutral protamine hagedorn.

It contains protamine, which is a protein that prolongs the action of the insulin.

That protein is what makes it look cloudy or milky.

And because it's prolonged, the timing is different.

Right.

Onset is one to two hours.

But the peak, and you always need to watch the peak because that's when hypoglycemia is most likely, is four to 12 hours.

That's a big window.

It is a big window.

So if you give it at 8 a .m., the patient is at highest risk around 2 p .m.

or 4 p .m.

Yeah.

You need to make sure they have a snack on board.

Finally, the long acting insulins.

Glargine, Detemir, Diglutic.

Let's focus on insulin Glargine for a second.

It has an onset of about 1 .5 hours, but here's the magic.

It has no peak.

No peak.

It is evenly distributed over a 24 -hour period.

This mimics the body's basal insulin secretion.

Because there's no peak, the risk of nocturnal hypoglycemia dropping low in the middle of the night is much lower.

You should give this once a day at bedtime.

One note on Glargine from the text.

It can sting.

Yes.

Glargine is acidic, so some patients report pain at the injection site compared to NPH.

And critically, you cannot mix Glargine with other insulin.

Which brings us to mixing.

Sometimes patients need both NPH and regular.

What is the rule Clear before cloudy.

Break it down.

Why?

Okay, so if you're mixing regular the clear one and NPH the cloudy one, in the same syringe you draw up the regular first.

The reason is contamination.

If you draw the cloudy first and you accidentally push a tiny bit of that protamine -laced cloudy insulin back into the clear regular vial, you have now contaminated the short acting vial with a long acting agent.

You've ruined the vial.

Ruined the vial.

So, clear regular first, then cloudy NTH.

Precisely.

Although the text does note that pre -mix options exist, like NPA70 regular 30 pens, so patients don't always have to do the mixing themselves.

That's a relief for dexterity issues.

Now we've talked about how insulin works, but we have to talk about when it works too well.

Adverse reactions.

Hypoglycemia.

Insulin shock.

This happens when there is more insulin than glucose.

What does that look like?

Nervousness, tremors, confusion, cold and clammy skin.

Slurred speech.

The text mentions tachycardia increased pulse rate.

And the treatment.

If they can swallow.

Orange juice.

Sugar sweetened beverage.

Hard candy.

Fast acting carbs.

If they cannot swallow or are unconscious.

Glucogon injection.

Now the text dives into two specific phenomena regarding morning blood sugar that can be really confusing.

The Symoji effect and the dawn phenomenon.

Both result in high blood sugar in the morning, but the causes and the treatments are opposites.

This is a critical concept.

Let's start with the Symoji effect.

This is a rebound response.

A redound from what?

Ideally, between 2 .00 am and 4 .0 am, the patient becomes hypoglycemic.

Their blood sugar drops too low during the night.

The body panics and releases hormones like cortisol, glucagon and epinephrine to save itself.

These hormones release stored sugar and by morning the patient is hypoglycemic.

So the morning high is a reaction to a nighttime low.

Correct.

Yeah.

So how do you fix it?

You reduce the bedtime insulin.

You stop the nighttime crash.

Okay.

Reduce the insulin for Symoji.

Now the dawn phenomenon.

This is different.

This is just hyperglycemia on awakening, often accompanied by headache and night sweats.

It's related to the natural release of growth hormone and cortisol in the early morning hours.

There is no nighttime crash here.

It's just a steady rise.

So the fix here.

Increase the bedtime insulin.

See, that's why you have to know the difference.

One you cut the dose, the other you increase it.

Exactly.

The text suggests monitoring blood glucose between 2 .00 a .m.

and 4 .00 a .m.

to tell them apart.

Right.

If they're low at 3 .0 a .m., it's Symoji.

If they're high or normal, it's likely dawn phenomenon.

Before we leave insulin, let's talk about administration.

We're going sub -Q.

Subcutaneous.

45 to 90 degree angle.

90 degrees if they have enough subcutaneous fat.

45 if they're thin or have very little muscle mass.

And where are we injecting?

Abdomen is best.

It has the fastest and most consistent absorption.

Thighs and buttocks are also options.

But the text is very strict about one thing.

Rotation.

Lycodystrophy.

Yes.

Tissue atrophy, lipoatrophy, or tissue hypertrophy, lipo -hypertrophy, basically lumps or depressions in the fat tissue.

This happens if you keep hitting the same spot.

And it interferes with insulin absorption.

So how do we rotate effectively?

The ADA suggests using one area, say the abdomen, for a week.

But within that area, you move the injection site about 1 .5 inches, you know, a knuckle length apart each day.

Then after a week, you switch to a different area, like the thigh.

So don't just jump from arm to leg to stomach every day.

Stick to a region, rotate within it, then move.

Correct.

It keeps absorption consistent.

And storage.

Unopened vials in the refrigerator.

Once opened, they can stay at room temperature for one month or in the fridge for three months.

Room temperature insulin hurts less when injected,

but avoids sunlight and freezing.

We've got pens, which are more accurate and portable.

We've got pumps, CSII, which provide a basal rate, and bolus doses.

Pumps are great for tight control, improving HbA1c, but they require a motivated patient who understands carbohydrate counting.

They use rapid acting insulin.

And there are even jet injectors that shoot insulin through the skin with high pressure.

Expensive and can cause bruising.

Not for everyone.

Okay, that is the world of insulin.

But for type 2 diabetics, the first line of defense is often oral anti -diabetic drugs.

Right.

And let's set the rules of engagement here.

These are primarily for type 2.

They require some functioning beta cells.

If you are type 1, your beta cells are gone, so these oral drugs generally won't work for you.

The text groups these by their mechanism.

Let's start with the sulfonylureas.

These are the stimulators.

Stimulator is a good word.

They stimulate the pancreatic beta cells to secrete more insulin.

They basically squeeze the pancreas.

We have first generation and second generation.

First generation, like tolbutamide, isn't used much anymore.

We focus on the second generation, glipizide and gleampyride.

They are stronger and have fewer side effects.

Let's look at the prototype, glipizide.

Onset is about 90 minutes, duration is 24 hours, so it's usually a once a day morning pill.

What's the major risk here?

Hypoglycemia.

Because it is actively squeezing the pancreas to release insulin, if you take this and don't eat, or if you take too much, your sugar can crash.

And there is a very specific drug interaction warning with sulfonylureas regarding alcohol.

Yes, the disulfiram -like reaction.

Oh, that's nasty.

It is nasty.

If you drink alcohol while taking a sulfonylurea, you can get flushing, headache,

sweating,

nausea, violent vomiting and weakness.

Patients need to be warned.

Okay, moving to the next class, the big one needs.

And the star of the show here is metformin.

Metformin is the most commonly prescribed drug for type 2 diabetes.

Its mechanism is completely different from sulfonylureas.

How so?

It does not stimulate insulin release.

Instead, it works on the liver.

It decreases the hepatic production of glucose.

It also decreases absorption in the small intestine and improves insulin receptor sensitivity.

So because it doesn't squeeze the pancreas?

It does not cause hypoglycemia when used alone.

That is a huge advantage.

But it's not without side effects.

GI disturbances are the big one.

Diarrhea, abdominal pain, also a bitter or metallic taste in the mouth.

And there is a severe adverse effect mention, lactic acidosis.

It's rare, but life -threatening.

Now there is a safety alert for metformin that every nurse knows, or should know.

It involves the radiology department.

By the Contrast Media, if a patient on metformin is going for a scan with dye, like a CT scan, they must withhold the metformin for 48 hours before and after the procedure.

Why?

Because the combination can lead to acute renal failure and lactic acidosis.

The kidneys just can't clear the drug properly with the dye present.

Okay, sulfonylureas squeeze, metformin stops the liver.

Let's do a rapid fire on the other oral classes, because the list is growing.

Let's do it.

Alpha -glucosidase inhibitors, acarbose, and miglitol.

These work in the intestine.

They inhibit the digestive enzyme that breaks down carbs.

So they delay carbohydrate absorption.

And the administration rule.

First bite.

They must be taken with the first bite of the meal.

If you take it after the meal, it's useless because the carbs are already absorbing.

Side effects are very GI -focused.

Yeah.

Flatulence, diarrhea.

Next, thiazolid and idiomes, piaglitazone and rosaglitazone.

These are insulin -enhancing agents.

They decrease insulin resistance.

But the big contraindication here is heart failure.

Class III or IV -V heart failure.

They cause fluid retention and edema, which can overload a failing heart.

Miglitonides, rapaglinide and netaglinide.

These act like sulfonylureas.

They stimulate beta cells.

But they are short -acting.

They shouldn't be used if there is liver dysfunction.

DPP4 inhibitors.

These are the gliptons, like cytagliptin.

These are incretin modifiers.

They increase insulin secretion, decrease glucagon.

Pretty straightforward.

And finally, the SGLT2 inhibitors, the flosins, like canagliflosin.

These are interesting.

They block glucose reabsorption in the kidneys.

Basically, they make you urinate out the excess sugar.

Which leads to the side effects.

If you have sugar in your urine, bacteria and yeast love it.

So UTIs, urinary tract infections and candidiasis, yeast infections are common side effects.

Also, polyuria, lots of peeing.

Okay, that covers the orals.

Now we have this category of injectable non -insulin drugs.

These are pens, but they aren't insulin.

Right.

We are talking about incretin memetics, or GLP -1 agonists.

Examples are exonetotide and liraglutide.

How do they work?

They mimic the incretin hormones.

They enhance insulin secretion, suppress glucagon, but importantly, they slow gastric emptying.

So the stomach stays full longer.

Exactly.

Which reduces food intake and can lead to weight loss.

But the side effects reflect that.

Nausea, vomiting, dizziness.

And there's one called pramlentide, an amylin analog.

The pramlentide is unique because it is approved for both type 1 and type 2.

Oh, for both?

Yes.

Yeah.

It also suppresses glucagon and slows gastric emptying to induce satiety.

And a specific injection warning for pramlentide?

Never in the arm.

Absorption is unpredictable.

Stick to the abdomen or thigh.

We've spent nearly an hour talking about how to lower blood sugar.

But what if we lower it too much?

We need the rescue drugs, the hyperglycemic drugs.

Glucagon is the go -to for insulin -induced hypoglycemic insulin shock.

When do we use it?

When the patient is semi -conscious or unconscious and cannot safely swallow sugar.

It works by stimulating glycogenolysis in the liver.

How fast?

Blood glucose rises within 10 minutes.

It can be given sub -Q, IM, or IV.

Families of type 1 diabetics often have emergency glucagon kits.

And then there is diazoxide.

Diazoxide is different.

It inhibits insulin release.

It is used for chronic hypoglycemia caused by hyperinsulinism like if the pancreas is producing too much insulin on its own.

It is not for insulin overdose reactions.

Okay.

We have covered the anatomy, the insulin, the orals, the injectables, and the rescues.

Now we need to bring this back to the bedside, clinical judgment, and the nursing process.

This is where we take the knowledge and apply it.

The recognize Qs step.

You are looking at a patient's chart.

What are you looking for?

Drug interactions.

We mentioned a few.

Diazoide diuretics and glucocorticoids increase glucose.

So insulin dose might need to go up.

Aspirin and oral anticoagulants increase the hypoglycemic effect.

So insulin might need to go down.

And assessing their knowledge.

Do they know how to administer?

Do they know the signs of high and low sugar?

Exactly.

It all comes back to education.

Let's walk through the case study provided in the text.

This really highlights how easy it is to make a mistake.

Right.

We have a 62 -year -old female, type 2 diabetes.

She is prescribed rapaglinide.

Remember, that's amyglitinide.

It stimulates insulin secretion.

The scenario says she missed her morning dose, so she took it at bedtime.

Then the next morning, she took a regular dose but skipped breakfast.

And the result?

Blood sugar, 50 -mil GDO,

hypoglycemia.

Why did this happen?

Two things.

First, stacking the doses too close together.

But primarily, she took an insulin stimulating drug, aglinide, without food.

The drug told the pancreas, release insulin, but there was no food to process.

So the insulin just ate up the baseline blood sugar.

So what is the correct action?

Immediate treatment for hypoglycemia.

Orange juice, get that sugar up.

And then patient teaching.

She needs to understand that rapaglinide must be taken with food.

If she skips a meal, she should skip the dose.

And the text outlines a safety rule.

If blood glucose is less than 70 -mil GDO, hold the drug and notify the provider.

Do not give an anti -diabetic drug to a patient who is already low.

Let's wrap up with a recap of the key patient teaching points.

Diet consistency is key.

Taking meds on a schedule.

Knowing the

Hyperglycemia.

Headaches, sweat, tremors.

Cold and clammy.

Need some candy.

And hyperglycemia.

Thirst.

Fruity breath.

That's the ketone's polyuria.

Hot and dry.

Sugar high.

And finally, medical alert.

Yes.

Wear a bracelet or tag.

If they're found unconscious, first responders need to know they are diabetic so they can check glucose immediately.

We have covered a massive amount of ground today.

From the alpha and beta cells of the pancreas to the clear before cloudy rule.

From the disulfiram reaction with gliposide to the lactic acidosis risk with metformin.

We've looked at the flozons that make you pee sugar and the GLP ones that make you feel full.

It is a complex landscape but the goal is simple.

Patient safety.

Preventing the highs like ketoacidosis and preventing the lows like hypoglycemic shock.

It's about understanding the mechanism so you can predict the result.

And that brings us to the end of this deep dive into chapter 50.

Hopefully the pancreas feels a little less mysterious now.

A huge thank you to the Last Minute Lecture team for helping us put this together.

And to you, the listener, keep asking questions, keep learning, and stay curious.

Stay safe out there.

See you next time.